Skip to main content
. 2017 Sep 18;19(11):857–867. doi: 10.1016/j.neo.2017.06.006

Table 3.

Candidate Genes Selected Using the Training Sets

Gene Gen Alta HRb 95% CIb P Valueb Frequencyc
GALNT10d, e Amp Mut 5.177 1.269-21.311 .022* 4
SOS1d, e Amp Mut 23 5.181-98.222 <.0001* 10
ZAP70d, e Amp Mut 4.524 1.765-11.598 .002* 5
FAM84Bd, e Amp 2.236 1.053-4.746 .036* 2
GRB2d, e Amp Mut 7.696 1.031-57.462 .047* 3
SIGLEC1d, e Amp Mut 6.46 1.98-21.074 .002* 4
CTNNB1d, e Amp Mut 6.553 1.883-22.808 .003* 5
APCd, e Homdel Mut 3.084 1.2-7.924 .019* 5
LYNd, e Amp Mut 2.535 0.993-6.471 .052 1
GALNT15d 7.645 1.013-57.701 .049* 1
ERBB2 2.464 0.614-9.889 .203 1
CTNND1 6.139 0.839-44.933 .074 2
GALNT2 1.776 0.536-5.888 .348 1
MUC1 0.365 0.037-3.597 .388 1
JUP 0.017 0.009-0.586 .024* 1
ABL1 0 0-0.005 0 1
a

Genomic alterations are included only for the final set of genes. Amp, amplification; Mut, mutation; Homdel, homdeletion.

b

Best HR, CI, and P value produced in 10 training sets.

c

Number of training sets from which the candidates were selected.

d

Candidates that are evaluated in 10 training sets.

e

The final set of genes or the nine-gene set.